Emerging at the UK, retatrutide, a innovative compound , is sparking considerable excitement within the healthcare community regarding its promise for weight management . This dual GIP and GLP-1 target agonist appears to offer a considerable benefit over existing therapies, showing positive results in initial clinical trials . Researchers suggest i